• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group.

作者信息

Bäckman L, Levy M F, Klintmalm G

机构信息

Transplantation Services, Baylor University Medical Center, Dallas, TX 75246.

出版信息

Transplant Proc. 1995 Feb;27(1):1124.

PMID:7533361
Abstract
摘要

相似文献

1
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group.
Transplant Proc. 1995 Feb;27(1):1124.
2
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization.FK506在肝移植中的应用：全血浓度与疗效及毒性的相关性。美国多中心FK506剂量优化研究。
Transplant Proc. 1995 Feb;27(1):1107.
3
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
Transplant Proc. 1995 Feb;27(1):1114-6.
4
Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation.
Transplant Proc. 1993 Aug;25(4):2688-90.
5
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Transplant Proc. 1995 Feb;27(1):1121-3.
6
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.肝移植后难治性排斥反应从环孢素转换为基于FK 506的免疫抑制治疗成功的预后因素。美国多中心FK 506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
7
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.使用普乐可复（FK506）作为肝移植后难治性排斥反应的挽救治疗。美国多中心FK506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):679-88.
8
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.肝移植受者的体重增加和血脂变化：美国FK506多中心研究的长期结果。
Transplant Proc. 1995 Feb;27(1):1126.
9
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.将环孢素转换用于难治性排斥反应成功后，使用FK 506预防同种异体移植复发排斥反应。美国多中心FK 506肝脏研究小组。
Transplant Proc. 1993 Feb;25(1 Pt 1):635-7.
10
FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients.FK506 对肝移植受者难治性排斥反应发作的挽救治疗。
Transplant Proc. 1991 Dec;23(6):2987-8.

引用本文的文献

1
Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.肝移植受者中与他克莫司相关的不良反应：其与谷浓度的关联
Indian J Gastroenterol. 2014 May;33(3):219-25. doi: 10.1007/s12664-014-0456-0. Epub 2014 Apr 18.
2
Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India.CYP3A5和CYP3A4基因多态性对印度北部肾移植受者中钙调神经磷酸酶抑制剂（环孢素和他克莫司）剂量需求的影响
Naunyn Schmiedebergs Arch Pharmacol. 2009 Aug;380(2):169-77. doi: 10.1007/s00210-009-0415-y. Epub 2009 Apr 3.
3
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
他克莫司在实体器官移植中的临床药代动力学与药效学
Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.
4
Clinical pharmacokinetics of tacrolimus.他克莫司的临床药代动力学
Clin Pharmacokinet. 1995 Dec;29(6):404-30. doi: 10.2165/00003088-199529060-00003.